(19)
(11) EP 1 539 805 A2

(12)

(88) Date of publication A3:
21.04.2005

(43) Date of publication:
15.06.2005 Bulletin 2005/24

(21) Application number: 02736898.4

(22) Date of filing: 15.05.2002
(51) International Patent Classification (IPC)7C07K 14/00, C07K 16/00, C07H 21/02, A61K 39/395, A61K 38/00, A61K 48/00, C12Q 1/68, G01N 33/53
(86) International application number:
PCT/US2002/015520
(87) International publication number:
WO 2002/092842 (21.11.2002 Gazette 2002/47)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 15.05.2001 US 291118 P
31.10.2001 US 1469
14.12.2001 US 17666

(71) Applicant: Agensys, Inc.
Santa Monica, CA 90404 (US)

(72) Inventors:
  • JAKOBOVITS, Aya
    Beverly Hills, CA 90210 (US)
  • FARIS, Mary
    Los Angeles, CA 90077 (US)
  • RAITANO, Arthur, B.
    Los Angeles, CA 90064 (US)
  • MORRISON, Robert, Kendall
    Santa Monica, CA 90403 (US)
  • SAFFRAN, Douglas
    Encinitas, CA 92024 (US)
  • GE, Wangmao
    Culver City, CA 90230 (US)
  • CHALLITA-EID, Pia, M.
    Encino, CA 91436 (US)

(74) Representative: Roques, Sarah Elizabeth 
J.A. Kemp & Co.14 South SquareGray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) NUCLEIC ACIDS AND CORRESPONSING PROTEINS ENTITLED 101P3A11 OR PHOR-1 USEFUL IN TREATMENT AND DETECTION OF CANCER